Spinal Muscular Atrophy Treatment Market Research Report by Type (Type 1, Type 2, Type 3, and Type 4), by Treatment (Drug Therapy and Gene Replacement Therapy), by Route of Administration - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Spinal Muscular Atrophy Treatment Market is expected to grow from USD 1,054.36 Million in 2020 to USD 2,063.21 Million by the end of 2025.
2. The Global Spinal Muscular Atrophy Treatment Market is expected to grow from EUR 924.48 Million in 2020 to EUR 1,809.06 Million by the end of 2025.
3. The Global Spinal Muscular Atrophy Treatment Market is expected to grow from GBP 821.87 Million in 2020 to GBP 1,608.26 Million by the end of 2025.
4. The Global Spinal Muscular Atrophy Treatment Market is expected to grow from JPY 112,527.77 Million in 2020 to JPY 220,197.08 Million by the end of 2025.
5. The Global Spinal Muscular Atrophy Treatment Market is expected to grow from AUD 1,531.08 Million in 2020 to AUD 2,996.05 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Spinal Muscular Atrophy Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the Spinal Muscular Atrophy Treatment Market studied across Type 1, Type 2, Type 3, and Type 4.
Based on Treatment, the Spinal Muscular Atrophy Treatment Market studied across Drug Therapy and Gene Replacement Therapy.
Based on Route of Administration, the Spinal Muscular Atrophy Treatment Market studied across Intrathecal and Oral.
Based on Geography, the Spinal Muscular Atrophy Treatment Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Spinal Muscular Atrophy Treatment Market including Biogen Inc., Cytokinetics, Inc., F. Hoffmann-La Roche AG, Ionis Pharmaceuticals, Inc., Isis Pharmaceuticals, Inc., Novartis International AG, Pfizer Inc., and PTC Therapeutics.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Spinal Muscular Atrophy Treatment Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Spinal Muscular Atrophy Treatment Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Spinal Muscular Atrophy Treatment Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Spinal Muscular Atrophy Treatment Market?
4. What is the competitive strategic window for opportunities in the Global Spinal Muscular Atrophy Treatment Market?
5. What are the technology trends and regulatory frameworks in the Global Spinal Muscular Atrophy Treatment Market?
6. What are the modes and strategic moves considered suitable for entering the Global Spinal Muscular Atrophy Treatment Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Spinal Muscular Atrophy Treatment Market is expected to grow from USD 1,054.36 Million in 2020 to USD 2,063.21 Million by the end of 2025.
2. The Global Spinal Muscular Atrophy Treatment Market is expected to grow from EUR 924.48 Million in 2020 to EUR 1,809.06 Million by the end of 2025.
3. The Global Spinal Muscular Atrophy Treatment Market is expected to grow from GBP 821.87 Million in 2020 to GBP 1,608.26 Million by the end of 2025.
4. The Global Spinal Muscular Atrophy Treatment Market is expected to grow from JPY 112,527.77 Million in 2020 to JPY 220,197.08 Million by the end of 2025.
5. The Global Spinal Muscular Atrophy Treatment Market is expected to grow from AUD 1,531.08 Million in 2020 to AUD 2,996.05 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Spinal Muscular Atrophy Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the Spinal Muscular Atrophy Treatment Market studied across Type 1, Type 2, Type 3, and Type 4.
Based on Treatment, the Spinal Muscular Atrophy Treatment Market studied across Drug Therapy and Gene Replacement Therapy.
Based on Route of Administration, the Spinal Muscular Atrophy Treatment Market studied across Intrathecal and Oral.
Based on Geography, the Spinal Muscular Atrophy Treatment Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Spinal Muscular Atrophy Treatment Market including Biogen Inc., Cytokinetics, Inc., F. Hoffmann-La Roche AG, Ionis Pharmaceuticals, Inc., Isis Pharmaceuticals, Inc., Novartis International AG, Pfizer Inc., and PTC Therapeutics.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Spinal Muscular Atrophy Treatment Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Spinal Muscular Atrophy Treatment Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Spinal Muscular Atrophy Treatment Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Spinal Muscular Atrophy Treatment Market?
4. What is the competitive strategic window for opportunities in the Global Spinal Muscular Atrophy Treatment Market?
5. What are the technology trends and regulatory frameworks in the Global Spinal Muscular Atrophy Treatment Market?
6. What are the modes and strategic moves considered suitable for entering the Global Spinal Muscular Atrophy Treatment Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Type Outlook
3.4. Treatment Outlook
3.5. Route of Administration Outlook
3.6. Geography Outlook
3.7. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET, BY TYPE
6.1. Introduction
6.2. Type
6.3. Type
6.4. Type
6.5. Type
7. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET, BY TREATMENT
7.1. Introduction
7.2. Drug Therapy
7.3. Gene Replacement Therapy
8. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION
8.1. Introduction
8.2. Intrathecal
8.3. Oral
9. AMERICAS SPINAL MUSCULAR ATROPHY TREATMENT MARKET
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. ASIA-PACIFIC SPINAL MUSCULAR ATROPHY TREATMENT MARKET
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand
11. EUROPE, MIDDLE EAST & AFRICA SPINAL MUSCULAR ATROPHY TREATMENT MARKET
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. COMPETITIVE LANDSCAPE
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion
13. COMPANY USABILITY PROFILES
13.1. Biogen Inc.
13.2. Cytokinetics, Inc.
13.3. F. Hoffmann-La Roche AG
13.4. Ionis Pharmaceuticals, Inc.
13.5. Isis Pharmaceuticals, Inc.
13.6. Novartis International AG
13.7. Pfizer Inc.
13.8. PTC Therapeutics
14. APPENDIX
14.1. Discussion Guide
14.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Type Outlook
3.4. Treatment Outlook
3.5. Route of Administration Outlook
3.6. Geography Outlook
3.7. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET, BY TYPE
6.1. Introduction
6.2. Type
6.3. Type
6.4. Type
6.5. Type
7. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET, BY TREATMENT
7.1. Introduction
7.2. Drug Therapy
7.3. Gene Replacement Therapy
8. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION
8.1. Introduction
8.2. Intrathecal
8.3. Oral
9. AMERICAS SPINAL MUSCULAR ATROPHY TREATMENT MARKET
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. ASIA-PACIFIC SPINAL MUSCULAR ATROPHY TREATMENT MARKET
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand
11. EUROPE, MIDDLE EAST & AFRICA SPINAL MUSCULAR ATROPHY TREATMENT MARKET
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. COMPETITIVE LANDSCAPE
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion
13. COMPANY USABILITY PROFILES
13.1. Biogen Inc.
13.2. Cytokinetics, Inc.
13.3. F. Hoffmann-La Roche AG
13.4. Ionis Pharmaceuticals, Inc.
13.5. Isis Pharmaceuticals, Inc.
13.6. Novartis International AG
13.7. Pfizer Inc.
13.8. PTC Therapeutics
14. APPENDIX
14.1. Discussion Guide
14.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE 1, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE 2, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE 3, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE 4, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY DRUG THERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GENE REPLACEMENT THERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY INTRATHECAL, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ORAL, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. AMERICAS SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. AMERICAS SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. AMERICAS SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. AMERICAS SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. ARGENTINA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. ARGENTINA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. ARGENTINA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. BRAZIL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. BRAZIL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. BRAZIL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. CANADA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. CANADA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. CANADA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. MEXICO SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. MEXICO SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. MEXICO SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. UNITED STATES SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. UNITED STATES SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. UNITED STATES SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. ASIA-PACIFIC SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. ASIA-PACIFIC SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. ASIA-PACIFIC SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. ASIA-PACIFIC SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. AUSTRALIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. AUSTRALIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. AUSTRALIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. CHINA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. CHINA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. CHINA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. INDIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. INDIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. INDIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. INDONESIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. INDONESIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. INDONESIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. JAPAN SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. JAPAN SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. JAPAN SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. MALAYSIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. MALAYSIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. MALAYSIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. PHILIPPINES SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. PHILIPPINES SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. PHILIPPINES SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. SOUTH KOREA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. SOUTH KOREA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. SOUTH KOREA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. THAILAND SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. THAILAND SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. THAILAND SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. EUROPE, MIDDLE EAST & AFRICA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. EUROPE, MIDDLE EAST & AFRICA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. EUROPE, MIDDLE EAST & AFRICA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. FRANCE SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. FRANCE SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. FRANCE SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. GERMANY SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. GERMANY SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. GERMANY SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. ITALY SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. ITALY SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. ITALY SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. NETHERLANDS SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. NETHERLANDS SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. NETHERLANDS SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. QATAR SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. QATAR SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. QATAR SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. RUSSIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. RUSSIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. RUSSIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. SAUDI ARABIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. SAUDI ARABIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. SAUDI ARABIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. SOUTH AFRICA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. SOUTH AFRICA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. SOUTH AFRICA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. SPAIN SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. SPAIN SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. SPAIN SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. UNITED ARAB EMIRATES SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. UNITED ARAB EMIRATES SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. UNITED ARAB EMIRATES SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. UNITED KINGDOM SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. UNITED KINGDOM SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. UNITED KINGDOM SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET: SCORES
TABLE 103. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET: BUSINESS STRATEGY
TABLE 104. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET: PRODUCT SATISFACTION
TABLE 105. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET: RANKING
TABLE 106. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET: MERGER & ACQUISITION
TABLE 107. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 108. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 109. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET: INVESTMENT & FUNDING
TABLE 110. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 111. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE 1, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE 2, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE 3, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE 4, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY DRUG THERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GENE REPLACEMENT THERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY INTRATHECAL, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ORAL, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. AMERICAS SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. AMERICAS SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. AMERICAS SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. AMERICAS SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. ARGENTINA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. ARGENTINA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. ARGENTINA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. BRAZIL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. BRAZIL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. BRAZIL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. CANADA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. CANADA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. CANADA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. MEXICO SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. MEXICO SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. MEXICO SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. UNITED STATES SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. UNITED STATES SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. UNITED STATES SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. ASIA-PACIFIC SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. ASIA-PACIFIC SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. ASIA-PACIFIC SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. ASIA-PACIFIC SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. AUSTRALIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. AUSTRALIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. AUSTRALIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. CHINA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. CHINA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. CHINA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. INDIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. INDIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. INDIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. INDONESIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. INDONESIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. INDONESIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. JAPAN SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. JAPAN SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. JAPAN SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. MALAYSIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. MALAYSIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. MALAYSIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. PHILIPPINES SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. PHILIPPINES SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. PHILIPPINES SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. SOUTH KOREA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. SOUTH KOREA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. SOUTH KOREA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. THAILAND SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. THAILAND SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. THAILAND SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. EUROPE, MIDDLE EAST & AFRICA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. EUROPE, MIDDLE EAST & AFRICA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. EUROPE, MIDDLE EAST & AFRICA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. FRANCE SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. FRANCE SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. FRANCE SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. GERMANY SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. GERMANY SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. GERMANY SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. ITALY SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. ITALY SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. ITALY SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. NETHERLANDS SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. NETHERLANDS SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. NETHERLANDS SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. QATAR SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. QATAR SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. QATAR SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. RUSSIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. RUSSIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. RUSSIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. SAUDI ARABIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. SAUDI ARABIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. SAUDI ARABIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. SOUTH AFRICA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. SOUTH AFRICA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. SOUTH AFRICA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. SPAIN SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. SPAIN SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. SPAIN SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. UNITED ARAB EMIRATES SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. UNITED ARAB EMIRATES SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. UNITED ARAB EMIRATES SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. UNITED KINGDOM SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. UNITED KINGDOM SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. UNITED KINGDOM SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET: SCORES
TABLE 103. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET: BUSINESS STRATEGY
TABLE 104. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET: PRODUCT SATISFACTION
TABLE 105. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET: RANKING
TABLE 106. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET: MERGER & ACQUISITION
TABLE 107. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 108. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 109. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET: INVESTMENT & FUNDING
TABLE 110. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 111. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 5. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2020 (USD MILLION)
FIGURE 6. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 (USD MILLION)
FIGURE 7. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 8. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 9. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 10. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2020 VS 2025 (%)
FIGURE 15. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2025
FIGURE 17. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE 1, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE 2, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE 3, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE 4, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2020 VS 2025 (%)
FIGURE 22. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2020 VS 2025 (USD MILLION)
FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2025
FIGURE 24. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GENE REPLACEMENT THERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2025 (%)
FIGURE 27. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2025 (USD MILLION)
FIGURE 28. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025
FIGURE 29. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY INTRATHECAL, 2020 VS 2025 (USD MILLION)
FIGURE 30. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ORAL, 2020 VS 2025 (USD MILLION)
FIGURE 31. AMERICAS SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 32. AMERICAS SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 33. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 34. ARGENTINA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 35. BRAZIL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 36. CANADA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. MEXICO SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. UNITED STATES SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. ASIA-PACIFIC SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 40. ASIA-PACIFIC SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 41. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 42. AUSTRALIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. CHINA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. INDIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. INDONESIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. JAPAN SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. MALAYSIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. PHILIPPINES SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. SOUTH KOREA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. THAILAND SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. EUROPE, MIDDLE EAST & AFRICA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 52. EUROPE, MIDDLE EAST & AFRICA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 53. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 54. FRANCE SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. GERMANY SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. ITALY SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. NETHERLANDS SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. QATAR SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. RUSSIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. SAUDI ARABIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. SOUTH AFRICA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. SPAIN SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. UNITED ARAB EMIRATES SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. UNITED KINGDOM SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 66. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 67. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 68. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET, BY TYPE
FIGURE 1. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 5. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2020 (USD MILLION)
FIGURE 6. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 (USD MILLION)
FIGURE 7. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 8. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 9. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 10. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2020 VS 2025 (%)
FIGURE 15. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE, 2025
FIGURE 17. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE 1, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE 2, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE 3, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TYPE 4, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2020 VS 2025 (%)
FIGURE 22. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2020 VS 2025 (USD MILLION)
FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY TREATMENT, 2025
FIGURE 24. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GENE REPLACEMENT THERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2025 (%)
FIGURE 27. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2025 (USD MILLION)
FIGURE 28. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025
FIGURE 29. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY INTRATHECAL, 2020 VS 2025 (USD MILLION)
FIGURE 30. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY ORAL, 2020 VS 2025 (USD MILLION)
FIGURE 31. AMERICAS SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 32. AMERICAS SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 33. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 34. ARGENTINA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 35. BRAZIL SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 36. CANADA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. MEXICO SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. UNITED STATES SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. ASIA-PACIFIC SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 40. ASIA-PACIFIC SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 41. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 42. AUSTRALIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. CHINA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. INDIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. INDONESIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. JAPAN SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. MALAYSIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. PHILIPPINES SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. SOUTH KOREA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. THAILAND SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. EUROPE, MIDDLE EAST & AFRICA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 52. EUROPE, MIDDLE EAST & AFRICA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 53. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 54. FRANCE SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. GERMANY SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. ITALY SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. NETHERLANDS SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. QATAR SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. RUSSIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. SAUDI ARABIA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. SOUTH AFRICA SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. SPAIN SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. UNITED ARAB EMIRATES SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. UNITED KINGDOM SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 66. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 67. GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 68. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET, BY TYPE
